Government commits $761 million to one drug maker for years

The US government awarded a $761 million contract to Ipsen Biopharmaceuticals. This means the government will buy pharmaceutical preparations from this company for five years.

This contract locks in a significant revenue stream for Ipsen for half a decade. It also secures a specific supply of drugs for the government. This kind of large, long-term commitment shapes a company's production plans and market position.